ezCOL performed a first-in-human clinical phase I/IIa study to produce the Proof of Concept (PoC) related to the efficacy and safety of the ezCOL cholesterol-lowering technology involving human volunteers with slightly elevated blood cholesterol (NCT03378999). Participant recruitment started in 2018 and was completed the same year counting 82 volunteers. This first clinical study has been initiate... Read more